myeloma
Category:
Current SOPs
| SOP Numbers | Date of Commencement | Incorporated Material | Status | |
|---|---|---|---|---|
| Reasonable Hypothesis | ||||
| 26/03/2024 | Current | Compilation | ||
| SOP Numbers | Date of Commencement | Incorporated Material | Status | |
|---|---|---|---|---|
| Balance of Probabilities | ||||
| 20/09/2021 | Current | Principal | ||
Past Versions of SOPs
| SOP Numbers | Date of Commencement | Status | ||
|---|---|---|---|---|
| Reasonable Hypothesis | Balance of Probabilities | |||
|
|
26/03/2024 | Current | Amendment | |
| 20/09/2021 | Current | Principal | ||
|
|
18/09/2017 | Revoked | Amendment | |
|
|
18/09/2017 | Revoked | Compilation | |
|
|
04/04/2016 | Revoked | Amendment | |
| 13/05/2014 | Revoked | Amendment | ||
|
|
13/05/2014 | Revoked | Compilation | |
| 31/10/2012 | Revoked | Principal | ||
| 19/11/2003 | Revoked | Principal | ||
| previously known as: multiple myeloma | ||||
| 10/11/1999 | Revoked | Principal | ||
| 09/10/1996 | Revoked | Principal | ||
| 18/01/1995 | Revoked | Principal | ||
Other Information
| Subject | Documents | Relevant SOPs | Date | Comment |
|---|---|---|---|---|
| Amendment Explanatory Statement tabled in Houses of Parliament | 27/2024 | 22/02/2024 | ||
| Explanatory Statements tabled in Houses of Parliament | 95/2021 96/2021 | 20/09/2021 | ||
| Reference List | 95/2021 96/2021 | 04/08/2021 |